Immuno-Oncology Company Elicio Therapeutics Launches with Novel Vaccine & Immunotherapy Platform to Treat an Array of Cancers
Park Square is pleased to announce the placement of Robert Connelly as Chief Executive Officer at Elicio Therapeutics.
Elicio Therapeutics, a next generation immuno-oncology company, engineering therapies for cancer killing immune responses, launched today...…